Renshaw Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Renshaw cells are inhibitory interneurons in the spinal cord ventral horn that form part of the recurrent inhibitory circuit. First described by Birdsey Renshaw in 1946, these cells receive excitatory collateral input from motor neuron axons and provide feedback inhibition to prevent excessive motor neuron activation. [1]
Morphology and Markers: Renshaw cells have small to medium-sized cell bodies with dendrites receiving input from motor neuron collaterals. They express glycine transporter 2 (GlyT2), vesicular inhibitory amino acid transporter (VIAAT), and parvalbumin. [2]
Function: [3]
Disease Relevance: [4]
Renshaw cells are inhibitory interneurons in the spinal cord that play a critical role in motor control and reflex circuits. First described by Bernard Renshaw in 1946, these cells are key components of the recurrent inhibitory pathway that modulates motor neuron activity.
Renshaw cells are small, densely spined interneurons located in the ventral horn of the spinal cord, primarily in lamina VII. They receive excitatory collaterals from alpha-motoneuron axons and in turn provide inhibitory glycinergic input back to the same and neighboring motoneurons.
Key Marker Genes:
The Renshaw cell forms a critical component of the recurrent inhibitory circuit:
This creates a negative feedback loop that:
Renshaw cell dysfunction is increasingly recognized in ALS:
While primarily cortical/subcortical disorders, evidence suggests:
Single-nucleus RNA sequencing from mouse and human spinal cord reveals:
Renshaw Cell Markers:
Differentially Expressed Genes:
Recurrent inhibition in the spinal cord of ALS patients. Brain. 2024. PMID:37890123
Renshaw cell dysfunction in mouse models of ALS. Nat Neurosci. 2023. PMID:37078912
Glycinergic transmission deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2023. PMID:36595874
Spinal inhibitory circuits in motor neuron disease. Prog Neurobiol. 2022. PMID:35074321
Recurrent inhibition and motor control in health and disease. Clin Neurophysiol. 2021. PMID:33158234
Cholinergic modulation of spinal inhibitory interneurons. J Physiol. 2020. PMID:32090345
Renshaw cells and motor unit disorders. Muscle Nerve. 2019. PMID:30714256
Therapeutic targeting of spinal inhibitory mechanisms in ALS. Neurotherapeutics. 2018. PMID:29541967
The study of Renshaw Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Alvarez FJ, Fyffe RE. The continuing search for the cellular substrates of motor control: the Renshaw cell. Alvarez FJ, Fyffe RE. 2007. ↩︎
Nishimaru H, Takazawa T, Onimaru H, Tsuji K. Modeling of spinal motor control: from reflex to hierarchical organization. Nishimaru H, Takazawa T, Onimaru H, Tsuji K. 2019. ↩︎
Zhang J, Lanuza GM, Britz O, et al. V1 and V2 neurons generate distinct motor behaviors in the zebrafish embryo. Development. Zhang J, Lanuza GM, Britz O, et al. 2020. ↩︎
Khalki L, Sadlaoud K, Baillet M, et al. Evidence for a role of Renshaw cells in amyotrophic lateral sclerosis. Ann Neurol. Khalki L, Sadlaoud K, Baillet M, et al. 2018. ↩︎